Université de Paris, Inserm U970, Paris-Cardiovascular Research Center, France (H.Q., R.A.-R., M.V., I.F., T.M., X.Z., I.S.-Z., G.G., P.A., E.R., G.A., D.B., S.T., A.T., C.M.B., S.B., X.J., H.A.-O.).
Division of Vascular and Endovascular Surgery, Department of Surgery and Department of Cell Biology, New York University Langone Medical Center (M.S., B.R.).
Circ Res. 2024 Aug 2;135(4):488-502. doi: 10.1161/CIRCRESAHA.124.324366. Epub 2024 Jul 9.
The long isoform of the Wnk1 (with-no-lysine [K] kinase 1) is a ubiquitous serine/threonine kinase, but its role in vascular smooth muscle cells (VSMCs) pathophysiology remains unknown.
AngII (angiotensin II) was infused in to induce experimental aortic aneurysm. Mice carrying an allele were cross-bred with mice carrying a floxed allele to specifically investigate the functional role of Wnk1 in VSMCs.
Single-cell RNA-sequencing of the aneurysmal abdominal aorta from AngII-infused mice revealed that VSMCs that did not express Wnk1 showed lower expression of contractile phenotype markers and increased inflammatory activity. Interestingly, WNK1 gene expression in VSMCs was decreased in human abdominal aortic aneurysm. -deficient VSMCs lost their contractile function and exhibited a proinflammatory phenotype, characterized by the production of matrix metalloproteases, as well as cytokines and chemokines, which contributed to local accumulation of inflammatory macrophages, Ly6C monocytes, and γδ T cells. mice spontaneously developed aortitis in the infrarenal abdominal aorta, which extended to the thoracic area over time without any negative effect on long-term survival. AngII infusion in mice aggravated the aortic disease, with the formation of lethal abdominal aortic aneurysms. Pharmacological blockade of γδ T-cell recruitment using neutralizing anti-CXCL9 (anti-CXC motif chemokine ligand 9) antibody treatment, or of monocyte/macrophage using Ki20227, a selective inhibitor of CSF1 receptor, attenuated aortitis. deletion in VSMCs led to aortic wall remodeling with destruction of elastin layers, increased collagen content, and enhanced local TGF-β (transforming growth factor-beta) 1 expression. Finally, in vivo TGF-β blockade using neutralizing anti-TGF-β antibody promoted saccular aneurysm formation and aorta rupture in mice but not in control animals.
Wnk1 is a key regulator of VSMC function. deletion promotes VSMC phenotype switch toward a pathogenic proinflammatory phenotype, orchestrating deleterious vascular remodeling and spontaneous severe aortitis in mice.
Wnk1(无赖氨酸[K]激酶 1)的长异构体是一种普遍存在的丝氨酸/苏氨酸激酶,但它在血管平滑肌细胞(VSMCs)病理生理学中的作用尚不清楚。
用血管紧张素 II(AngII)输注诱导实验性主动脉瘤。将携带 等位基因的小鼠与携带 floxed 等位基因的小鼠杂交,以专门研究 Wnk1 在 VSMCs 中的功能作用。
对 AngII 输注的 小鼠腹主动脉瘤的单细胞 RNA 测序显示,不表达 Wnk1 的 VSMCs 表现出收缩表型标志物的表达降低和炎症活性增加。有趣的是,人类腹主动脉瘤中 WNK1 基因表达降低。-缺陷的 VSMCs 失去了它们的收缩功能,并表现出促炎表型,其特征是产生基质金属蛋白酶以及细胞因子和趋化因子,这导致炎症巨噬细胞、Ly6C 单核细胞和 γδ T 细胞在局部的积累。 小鼠在肾下腹部主动脉自发发生主动脉炎,随着时间的推移扩展到胸部区域,对长期生存没有任何负面影响。AngII 输注在 小鼠中加重了主动脉疾病,形成致命的腹主动脉瘤。使用中和抗-CXCL9(CXC 基序趋化因子配体 9)抗体治疗或使用 CSF1 受体选择性抑制剂 Ki20227 抑制 γδ T 细胞募集或单核细胞/巨噬细胞,可减轻主动脉炎。VSMCs 中的 缺失导致主动脉壁重塑,弹性层破坏,胶原含量增加,局部 TGF-β(转化生长因子-β)1 表达增强。最后,体内使用中和抗 TGF-β 抗体阻断 TGF-β 促进了 小鼠的囊状动脉瘤形成和主动脉破裂,但在对照动物中没有。
Wnk1 是 VSMC 功能的关键调节因子。 缺失促进 VSMC 表型向促炎表型转变,协调小鼠有害的血管重塑和自发性严重主动脉炎。